BDX icon

Becton Dickinson

175.41 USD
+3.14
1.82%
At close May 16, 4:00 PM EDT
After hours
175.41
+0.00
0.00%
1 day
1.82%
5 days
2.38%
1 month
-12.47%
3 months
-22.09%
6 months
-21.73%
Year to date
-22.55%
1 year
-25.87%
5 years
-33.75%
10 years
23.87%
 

About: Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.

Employees: 74,000

0
Funds holding %
of 7,457 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

278% more call options, than puts

Call options by funds: $792M | Put options by funds: $209M

25% more funds holding in top 10

Funds holding in top 10: 20 [Q4 2024] → 25 (+5) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 128 | Existing positions closed: 128

2% less repeat investments, than reductions

Existing positions increased: 589 | Existing positions reduced: 600

4% less capital invested

Capital invested by funds: $60.4B [Q4 2024] → $57.9B (-$2.5B) [Q1 2025]

1.76% less ownership

Funds ownership: 89.78% [Q4 2024] → 88.02% (-1.76%) [Q1 2025]

3% less funds holding

Funds holding: 1,597 [Q4 2024] → 1,551 (-46) [Q1 2025]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$185
5%
upside
Avg. target
$217
23%
upside
High target
$261
49%
upside

4 analyst ratings

positive
75%
neutral
25%
negative
0%
Morgan Stanley
Patrick Wood
50% 1-year accuracy
8 / 16 met price target
12%upside
$196
Overweight
Maintained
6 May 2025
Piper Sandler
Jason Bednar
35% 1-year accuracy
14 / 40 met price target
5%upside
$185
Neutral
Downgraded
2 May 2025
Stifel
Rick Wise
45% 1-year accuracy
15 / 33 met price target
28%upside
$224
Buy
Maintained
2 May 2025
Barclays
Travis Steed
33% 1-year accuracy
2 / 6 met price target
49%upside
$261
Overweight
Maintained
7 Apr 2025

Financial journalist opinion

Based on 29 articles about BDX published over the past 30 days

Positive
Seeking Alpha
1 hour ago
35 Barron's Pro-Picks: One Ideal May DiviDog
Barron's interviewed eleven financial industry Roundtable-pros who tapped 65 predictions. Six non-ADR foreign-stocks and four mutual funds were dropped by YCharts screens of active US listings, leaving 55. AT&T stands out as the only 'safer' ideal dividend dog, with its price well below annual dividends from a $1,000 investment. Top ten yield picks project average 28.12% total return by May 2026, with risk/volatility 12% below the market average.
35 Barron's Pro-Picks: One Ideal May DiviDog
Positive
24/7 Wall Street
3 days ago
UNH, TGT, BDX: 3 Ridiculously Undervalued Stocks Set to Surge in May 2025
These stocks have declined significantly in the past year and are now below their intrinsic values.
UNH, TGT, BDX: 3 Ridiculously Undervalued Stocks Set to Surge in May 2025
Neutral
Seeking Alpha
4 days ago
Becton, Dickinson and Company (BDX) Bank of America Securities Health Care Conference - (Transcript)
Becton, Dickinson and Company (NYSE:BDX ) Bank of America Securities Health Care Conference Call May 13, 2025 1:00 PM ET Company Participants Tom Polen - Chairman, Chief Executive Officer and President Conference Call Participants Travis Steed - Bank of America Securities Travis Steed [Starts Abruptly] I'm Travis Steed, Medical Device Analyst at Bank of America and I'm fortunate to have Tom Polen up next, CEO at Becton, Dickinson. So welcome.
Becton, Dickinson and Company (BDX) Bank of America Securities Health Care Conference - (Transcript)
Neutral
PRNewsWire
5 days ago
BD to Announce Financial Results for its Third Quarter of Fiscal 2025
FRANKLIN LAKES, N.J. , May 12, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m.
BD to Announce Financial Results for its Third Quarter of Fiscal 2025
Positive
Kiplinger
1 week ago
The Best Health Care Stocks to Buy
The best health care stocks offer investors a defensive hedge in an uncertain market. Here's how to find them.
The Best Health Care Stocks to Buy
Positive
Seeking Alpha
1 week ago
Buy 3 "Safer" Dividend Kings Of 25 From May's 55
The May collection of Dividend Kings grew to 55, with Automatic Data Processing and RLI Corporation joining, despite two companies dropping off for not increasing dividends. Six top-yield Dividend Kings, including Altria and Canadian Utilities, are now fairly priced, with annual dividends from $1K investments exceeding their single-share prices. Analysts predict net gains of 14.7% to 56.86% for the top ten Dividend Kings by yield for the coming year, based on target prices. Among the 55 Dividend Kings, 16 show negative free cash flow margins, making them cash-poor and unsafe for investment.
Buy 3 "Safer" Dividend Kings Of 25 From May's 55
Negative
Benzinga
2 weeks ago
Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years
Becton Dickinson, and Company BDX lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday.
Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years
Positive
Benzinga
2 weeks ago
Stock Of The Day – Bullish Capitulation In Becton, Dickinson?
Shares of Becton, Dickinson and Company  BDX are coming back a little on Friday. This follows Thursday's more than 18% drop.
Stock Of The Day – Bullish Capitulation In Becton, Dickinson?
Positive
Seeking Alpha
2 weeks ago
9 Dividend Aristocrats Potentially Set To Soar, No Matter What Happens Next
I'm going on a 2-week vacation with my family for my sister's wedding, so I've prepared a comprehensive article with three types of dividend aristocrat recommendations for whateveriscomingnext. Low-volatility aristocrats offer a 3.4% yield, a 46% downside capture ratio, and 52% less volatility than the S&P, making them ideal for addressing recession concerns while still providing a 23% return. High-yield aristocrats offer a 7% average yield with 11%-12% long-term return potential, providing low-risk income regardless of market or economic conditions.
9 Dividend Aristocrats Potentially Set To Soar, No Matter What Happens Next
Negative
Market Watch
2 weeks ago
Medical-products maker Becton Dickinson says cuts in global research funding have hurt sales
Becton Dickinson & Co.'s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after the medical-products maker said global cuts in research funding are impacting its research instrument sales.
Medical-products maker Becton Dickinson says cuts in global research funding have hurt sales
Charts implemented using Lightweight Charts™